| Literature DB >> 34566342 |
Prudence Mpundu1,2, Allan Rabson Mbewe3, John Bwalya Muma2, Wizaso Mwasinga2, Nawa Mukumbuta1,4, Musso Munyeme2.
Abstract
BACKGROUND AND AIM: Listeria monocytogenes in ready-to-eat (RTE) foods remains consistently under-reported globally. Nevertheless, several independent studies conducted to investigate have elucidated the prevalence and antibiotic resistance profiles of L. monocytogenes in RTE-associated foods and their antibiotic resistance profiles. Given the rapid increase in consumption of RTE foods of both animal and plant origin, it is imperative to know the prevalence deductive data focusing on how much of L. monocytogenes is present in RTE foods, which is critical for food safety managers and retailers to assess the possible risk posed to end-users. In addition, valuable insight and another angle to the depth of the problem, we conducted a systematic review and meta-analysis to synthesize available data regarding the prevalence of L. monocytogenes in RTE foods and antibiotic resistance profiles.Entities:
Keywords: Listeria monocytogenes; antibiotic resistance; ready-to-eat foods
Year: 2021 PMID: 34566342 PMCID: PMC8448623 DOI: 10.14202/vetworld.2021.2219-2229
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1The flow diagram of the literature search and selection of eligible studies.
Number of publications reviewed by continent and the type of foods reported.
| Food Type | Number of publications continents | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Europe (n=15) | Asia (n=12) | Africa (n=7) | North America (n=2) | South America (n=2) | Total | |
| Beef products | 8 | 8 | - | - | 16 | |
| Milk | 7 | 2 | 5 | - | - | 14 |
| Fish | 14 | 8 | 2 | - | - | 24 |
| Salads | 9 | 4 | 2 | - | 2 | 17 |
| Pork | 4 | - | - | - | - | 4 |
| Vegetable product | 2 | 4 | 1 | 4 | - | 11 |
| Chicken product | 1 | 9 | 5 | - | - | 15 |
| Assorted ready-to-eat foods | 7 | 8 | 3 | 2 | - | 20 |
| Total | 52 | 43 | 18 | 6 | 2 | 121 |
Distribution of antibiotics resistance across different types of ready-to-eat foods.
| Antibiotics | Type of food | ||||
|---|---|---|---|---|---|
|
| |||||
| Assorted foods | Poultry products | Ready-to-eat salads | Fish product | Total | |
| Aminoglycosides | 12 | 2 | 5 | 0 | 19 |
| Antimycobacterials | 4 | 1 | 1 | 0 | 6 |
| Carbapenem | - | 0 | 0 | 1 | 1 |
| Cephalosporin’s | 10 | 0 | 0 | 2 | 12 |
| Fluoroquinolones | 1 | 0 | 1 | 0 | 2 |
| Glycopeptide | 7 | 1 | 0 | 1 | 9 |
| Lincomycin | 3 | 0 | 1 | 2 | 6 |
| Macrolides | 6 | 1 | 2 | 1 | 10 |
| Nitrofurantoin | 1 | 0 | 0 | 0 | 1 |
| Oxytetracycline | 1 | 0 | 0 | 0 | 1 |
| Penicillins | 20 | 3 | 2 | 7 | 32 |
| Quinolone | 12 | 2 | 2 | 4 | 20 |
| Sulfonamides | 5 | 1 | 0 | 1 | 7 |
| Tetracycline | 9 | 1 | 2 | 3 | 15 |
| Total | 91 | 12 | 16 | 22 | 141 |
Country prevalence of Listeria monocytogenes contamination ready-to-eat foods and global pooled prevalence.
| Country | No. of studies | ESa | Lower | Upper | Weight | Heterogeneity | Degrees of freedom | p-value | I2(%)d |
|---|---|---|---|---|---|---|---|---|---|
| Spain | 3 | 0.090 | 0.045 | 0.131 | 11.52 | 19.19 | 7 | 0.008 | 63.5 |
| Italy | 2 | 0.271 | 0.194 | 0.347 | 3.31 | 3.28 | 4 | 0.512 | 0.0 |
| Japan | 2 | 0.063 | 0.004 | 0.121 | 5.76 | 0.84 | 10 | 1.000 | 0.0 |
| Turkey | 2 | 0.110 | −0.045 | 0.268 | 0.78 | 0.10 | 3 | 0.992 | 0.0 |
| Sebia | 1 | 0.251 | 0.146 | 0.355 | 1.78 | 1.72 | 1 | 0.190 | 41.7 |
| Northern Ireland | 1 | 0.084 | −0.010 | 0.178 | 2.20 | 0.82 | 2 | 0.664 | 0.0 |
| Sweden | 1 | 0.232 | 0.175 | 0.289 | 6.01 | 49.22 | 4 | 0.000 | 91.9 |
| Greece | 2 | 0.081 | −0.055 | 0.217 | 1.05 | 0.46 | 4 | 0.977 | 0.0 |
| Estonia | 1 | 0.045 | 0.022 | 0.67 | 38.96 | 44.82 | 7 | 0.000 | 84.4 |
| Iran | 3 | 0.276 | 0.186 | 0.365 | 2.44 | 48.56 | 5 | 0.000 | 89.7 |
| Egypt | 1 | 0.233 | −0.010 | 0.476 | 0.33 | 0.64 | 1 | 0.423 | 0.0 |
| India | 1 | 0.052 | −0.225 | 0.329 | 0.25 | 0.02 | 1 | 0.886 | 0.0 |
| Algeria | 1 | 0.063 | −0.114 | 0.240 | 0.62 | 0.12 | 1 | 0.732 | 0.0 |
| Ethiopia | 1 | 0.089 | −0.059 | 0.237 | 0.89 | 0.24 | 3 | 0.971 | 0.0 |
| United Kingdom | 3 | 0.133 | 0.075 | 0.191 | 5.85 | 11.58 | 5 | 0.041 | 56.8 |
| Malaysia | 5 | 0.139 | 0.079 | 0.199 | 5.48 | 12.64 | 18 | 0.812 | 0.0 |
| Brazil | 2 | 0.176 | 0.0 | 0.049 | 0.304 | 1.20 | 21.61 | 0.001 | 76.9 |
| Nigeria | 2 | 0.241 | 0.159 | 0.322 | 2.97 | 23.66 | 3 | 0.000 | 87.3 |
| China | 5 | 0.053 | −0.012 | 0.118 | 4.58 | 1.31 | 6 | 0.971 | 0.0 |
| Thailand | 1 | 0.147 | 0.022 | 0.273 | 1.24 | 0.33 | 1 | 0.563 | 0.0 |
| Jordon | 1 | 0.563 | 0.426 | 0.699 | 1.06 | 14.82 | 2 | 0.001 | 86.5 |
| Sudan | 2 | 0.124 | 0.018 | 0.230 | 1.74 | 1.20 | 4 | 0.879 | 0.0 |
| Overall | 43 | 0.108 | 0.094 | 0.122 | 100.0 | 407.82 | 118 | <0.000 | 71.1 |
The global pooled prevalence of antibiotic resistance of Listeria monocytogenes in ready-to-eat foods.
| Country | No. of studies | ESa | Lower | Upper | Weight of ES (%) b | Heterogeneity statistic | Degrees of freedom | p-value | I2(%)d |
|---|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 0.250 | 0.005 | 0.495 | 0.42 | 0.00 | 1 | 1.000 | 0.0 |
| China | 5 | 0.146 | 0.115 | 0.178 | 26.24 | 201.7 | 37 | 0.000 | 81.7 |
| Ethiopia | 1 | 0.487 | 0.344 | 0.631 | 1.24 | 5.80 | 3 | 0.122 | 48.3 |
| Iran | 2 | 0.267 | 0.225 | 0.308 | 14.78 | 53.57 | 18 | 0.000 | 66.4 |
| Jordan | 1 | 0.121 | −0.137 | 0.378 | 0.38 | 0.13 | 2 | 0.936 | 0.0 |
| Korea | 1 | 0.941 | 0.883 | 1.00 | 7.44 | 24.52 | 1 | 0.000 | 95.9 |
| Malaysia | 1 | 0.802 | 0.696 | 0.908 | 2.27 | 7.32 | 2 | 0.026 | 72.7 |
| Nigeria | 2 | 0.469 | 0.441 | 0.496 | 33.62 | 120.67 | 19 | 0.000 | 84.3 |
| Spain | 1 | 0.164 | 0.004 | 0.324 | 0.99 | 0.59 | 6 | 0.997 | 0.0 |
| Taiwan | 1 | 0.091 | −0.306 | 0.488 | 0.16 | 0.00 | 0 | - | - |
| Turkey | 4 | 0.448 | 0.392 | 0.504 | 8.04 | 142.60 | 24 | 0.000 | 83.2 |
| Overall | 20 | 0.381 | 0.365 | 0.397 | 100.0 | 1342.08 | 136 | 0.000 | 89.9 |
Effect size (ES): Prevalence of antibiotic resistance in ready-to-eat foods (ratio of positive samples/total samples). The weight of ES is related to the total sample size of individual studies. Variation in study outcomes between studies. Heterogeneity across studies (I2)
Prevalence of Listeria monocytogenes contamination in ready-to-eat foods.
| Item | Country | No. of Papers | Effect size | 95% CI | Weight | I Squared (%) | p-value |
|---|---|---|---|---|---|---|---|
| Spain | 2 | 0.25 | 0.08, 0.43 | 27.61 | 86.6 | <0.001 | |
| Milk products | Italy | 1 | 0.02 | 0.52, 0.56 | 2.75 | 0 | <0.001 |
| Sweden | 1 | 0.36 | 0.29, 1.05 | 1.79 | 0 | <0.001 | |
| Estonia | 2 | 0.21 | 0.07, 0.35 | 41.28 | 0 | 0.578 | |
| India | 2 | 0.05 | 0.23, 0.33 | 10.6 | 0 | 0.886 | |
| Ethiopia | 2 | 0.07 | 0.15, 0.30 | 15.97 | 0 | 0.678 | |
| Overall | 10 | 0.18 | 0.09, 0.27 | 100 | 46.5 | 0.044 | |
| Fish products | Spain | 2 | 0.08 | 0.02, 0.14 | 28.24 | 0 | 0.685 |
| Italy | 1 | 0.34 | 0.20, 0.48 | 5.66 | 0 | 0.001 | |
| Japan | 1 | 0.08 | −0.01, 0.14 | 21.13 | 0 | 0.999 | |
| Turkey | 1 | 0.12 | −0.25, 0.49 | 0.8 | 0 | 0.001 | |
| Sebia | 1 | 0.25 | 0.15, 0.36 | 9.88 | 41.7 | 0.19 | |
| Northern Ireland | 1 | 0.01 | −0.31, 0.34 | 0.01 | 0 | 0.001 | |
| Sweden | 1 | 0.12 | 0.06, 0.19 | 25.84 | 0 | 0.449 | |
| Greece | 1 | 3.34 | −0.12, 0.24 | 3.34 | 0 | 0.923 | |
| Estonia | 1 | 0.06 | −0.42, 0.53 | 0.48 | 0 | 0 | |
| Iran | 1 | 0.06 | −0.20, 0.30 | 1.78 | 12.4 | 0 | |
| Egypt | 1 | 0.23 | −0.01, 0.48 | 1.84 | 0.423 | 0 | |
| Overall | 12 | 0.12 | 0.09, 0.15 | 100.0 | 12.4 | 0.289 | |
| Pork products | Spain | 1 | 0.08 | 0.03, 0.14 | 100 | 0 | 0.736 |
| Ready-to-eat salads | Italy | 1 | 0.27 | 0.16, 0.38 | 13.91 | 0 | 0 |
| Turkey | 1 | 0.18 | −0.35, 0.71 | 0.56 | 0 | 0 | |
| Northern Ireland | 1 | O.O4 | −0.13, 0.20 | 5.8 | 0 | 0 | |
| Estonia | 1 | 0.19 | 0.11, 0.26 | 27.69 | 0 | 0 | |
| Iran | 1 | 0.31 | 0.03, 0.59 | 1.96 | 0 | 0 | |
| United Kingdom | 1 | 0.04 | −0.06, 0.13 | 17.13 | 0 | 0 | |
| Malaysia | 3 | 0.14 | 0.07,0.22 | 26.31 | 25.4 | 0.235 | |
| Brazil | 2 | 0.68 | 0.38, 098 | 1.76 | 85 | 0.001 | |
| Nigeria | 2 | 0.2 | 0.02, 0.38 | 4.89 | 46.6 | 0.171 | |
| Overall | 13 | 0.16 | 0.12, 0.20 | 100.0 | 62.4 | <0.001 | |
| Beef products | Japan | 1 | 0.07 | 0.21,0.35 | 0.58 | 0 | 0.787 |
| Northern Ireland | 1 | 0.12 | −0.00,0.24 | 3.08 | 0 | 0 | |
| Sweden | 1 | 0.61 | 0.49,0.73 | 3.11 | 0 | 0 | |
| Estonia | 1 | 0.02 | −0.00,0.04 | 80.32 | 0 | 0 | |
| Iran | 2 | 0.33 | 0.21,0.45 | 3.13 | 95.5 | 0.001 | |
| United Kingdom | 1 | 0.02 | −0.16,0.20 | 1.4 | 0.991 | 0.001 | |
| Malaysia | 1 | 0.07 | −0.28,0.41 | 0.39 | 0 | 0 | |
| China | 4 | 0.05 | 0.03,0.12 | 7.75 | 0 | 0.743 | |
| Thailand | 1 | 0.27 | −0.16,0.71 | 0.24 | 90.3 | 0.001 | |
| Overall | 13 | 0.16 | 0.12, 0.20 | 100.0 | 62.4 | <0.001 | |
| Chicken products | Turkey | 1 | 0.1 | −0.11, 0.32 | 7.7 | 0 | 0 |
| Iran | 1 | 0.26 | 0.07, 0.45 | 9.93 | 0 | 0 | |
| Malaysia | 1 | 0.22 | 0.05, 0.40 | 11.64 | 0 | 0.972 | |
| China | 2 | 0.07 | −0.06, 0.20 | 20.5 | 0 | 0.965 | |
| Jordan | 1 | 0.56 | −0.43, 0.70 | 18.95 | 86.5 | 0.001 | |
| Sudan | 1 | 0.12 | −0.02, 0.23 | 31.28 | 0 | 0.879 | |
| Overall | 7 | 0.22 | −0.16, 0.28 | 100.0 | 72.1 | <0.001 | |
| Assorted ready-to-eat | Italy | 1 | 0.1 | −0.19,0.39 | 2.44 | 0 | 0 |
| Japan | 1 | 0.09 | −0.05, 0.24 | 9.85 | 0 | 0 | |
| Greece | 1 | 0.1 | −0.10, 0.31 | 4.86 | 0 | 0.986 | |
| Estonia | 1 | 0.47 | 0.26, 0.67 | 5.09 | 80.7 | 0.023 | |
| Algeria | 1 | 0.14 | −0.34, 0.83 | 0.9 | 0 | 0 | |
| Ethiopia | 1 | 0.1 | 0.10, 0.30 | 5.45 | 0 | 0.916 | |
| United Kingdom | 3 | 0.22 | 0.14, 0.30 | 33.65 | 0 | 0.411 | |
| Malaysia | 1 | 0.1 | −0.04, 0.23 | 11.64 | 0 | 0.609 | |
| Nigeria | 1 | 0.48 | 0.35, 0.61 | 12.06 | 0 | 0 | |
| China | 1 | 0.06 | −0.28, 0.41 | 1.8 | 0 | 0 | |
| Thailand | 1 | 0.14 | 0.01, 0.27 | 12.24 | 54.7 | 0.002 | |
| Overall | 13 | 0.21 | 0.16, 0.25 | 100.0 | 54.7 | 0.002 |
The global pooled prevalence of contamination of ready-to-eat foods with antibiotic-resistant Listeria monocytogenes.
| Item | Country | No. of papers | Effect size | 95% CI | Weight | I Squared (%) | p-value |
|---|---|---|---|---|---|---|---|
| Aminoglycosides | China | 7 | 0.07 | −0.00, 0.14 | 60.75 | 0.0 | 0.985 |
| Iran | 2 | 0.10 | −0.17, 0.28 | 1.77 | 0.0 | 0.855 | |
| Italy | 2 | 0.06 | 0.17, 0.28 | 6.27 | 0.0 | 0.855 | |
| Jordan | 1 | 0.06 | −0.41, 0.52 | 1.46 | 0.0 | <0.001 | |
| Nigeria | 2 | 0.26 | 0.11, 0.40 | 14.56 | 39.3 | 0.176 | |
| Spain | 1 | 0.21 | 0.25, 0.68 | 1.48 | 0.0 | <0.001 | |
| Turkey | 2 | 0.39 | 0.24, 0.55 | 13.70 | 83.0 | 0.001 | |
| Overall | 17 | 0.07 | −0.00, 0.14 | 60.75 | 0.0 | 0.985 | |
| Antimycobacterials | China | 3 | 0.05 | −0.06, 0.15 | 55.38 | 0.0 | 0.832 |
| Iran | 1 | 0.08 | −0.11, 0.27 | 17.84 | 0.0 | <0.001 | |
| Malaysia | 1 | 0.83 | 0.66, 1.00 | 21.40 | 0.0 | <0.001 | |
| Turkey | 1 | 0.47 | 0.12, 0.82 | 5.38 | 0.0 | <0.001 | |
| Overall | 6 | 0.24 | 0.16, 0.32 | 100.0 | 91.9 | 0.001 | |
| Carbapenem | Turkey | 1 | 0.06 | −0.37, 0.49 | 100.0 | 0.0 | < 0.001 |
| Cephalosporin’s | China | 3 | 0.52 | 0.44, 0.59 | 14.61 | 95.9 | 0.001 |
| Italy | 1 | 0.15 | −0.36 ,0.44 | 0.52 | 0.0 | <0.001 | |
| Nigeria | 1 | 0.47 | 0.44, 0.50 | 82.99 | 0.0 | 0.990 | |
| Spain | 1 | 0.21 | −0.25, 0.67 | 0.39 | 0.0 | <0.001 | |
| Turkey | 1 | 0.15 | −0.08, 0.39 | 1.49 | 0.0 | 0.678 | |
| Overall | 7 | 0.47 | 0.44, 0.50 | 100.0 | 88.3 | 0.001 | |
| Fluoroquinolones | Iran | 2 | 0.23 | 0.11, 0.35 | 100.0 | 0.0 | 0.430 |
| Glycopeptide | China | 2 | 0.02 | −0.13, 0.16 | 33.37 | 0.0 | 0.925 |
| Iran | 1 | 0.35 | 0.19, 0.51 | 27.68 | 0.0 | <0.001 | |
| Italy | 1 | 0.06 | −0.15, 0.27 | 15.36 | 0.0 | 0.908 | |
| Nigeria | 1 | 0.57 | 0.23 ,0.91 | 5.87 | 0.0 | <0.001 | |
| Spain | 1 | 0.21 | −0.25, 0.67 | 3.25 | 0.0 | <0.001 | |
| Turkey | 2 | 0.49 | 0.27, 0.71 | 14.46 | 67.1 | 0.081 | |
| Overall | 8 | 0.22 | 0.14, 0.31 | 100.0 | 68.2 | 0.001 | |
| Lincomycins | China | 1 | 0.34 | 0.16, 0.52 | 28.49 | 0.0 | < 0.001) |
| Iran | 2 | 0.06 | −0.07, 0.20 | 49.77 | 0.0 | 0.761 | |
| Italy | 1 | 0.28 | 0.02, 0.53 | 13.53 | 0.0 | <0.001 | |
| Korea | 1 | 0.28 | 0.02, 0.53 | 0.0 | 0.0 | <0.001 | |
| Turkey | 2 | 0.13 | −0.20, 0.47 | 8.21 | 0.0 | <0.001 | |
| Overall | 7 | 0.17 | 0.08, 0.27 | 100.0 | 39.9 | 0.001 | |
| Penicillins | China | 3 | 0.05 | −0.03, 0.12 | 17.78 | −0.0 | 0.981 |
| Ethiopia | 1 | 0.87 | 0.44, 0.90 | 2.07 | 0.0 | <0.001 | |
| Iran | 2 | 0.30 | 0.31, 0.48 | 15.12 | −0.0 | 0.435 | |
| Italy | 1 | 0.47 | 0.36, 0.50 | 8.60 | −88.8 | 0.001 | |
| Korea | 1 | 0.97 | 0.911,1.3 | 31.08 | 0.0 | <0.001 | |
| Malaysia | 1 | 0.97 | 0.91, 1,03 | 0.0 | 0.0 | <0.001 | |
| Nigeria | 2 | 0.88 | 0.78, 0.90 | 10.45 | −0.0 | 0.58 | |
| Spain | 1 | 0.07 | −0.25, 0.37 | 1.24 | 0.0 | <0.001 | |
| Taiwan | 1 | 0.09 | −0.31, 0.49 | 0.70 | 0.0 | <0.001 | |
| Turkey | 3 | 0.89 | 0.50, 0.78 | 11.58 | −93.5 | <0.001 | |
| Overall | 16 | 0.80 | 0.57, 0.64 | 100.0 | 94.9 | 0.001 | |
| Quinolones | China | 3 | 0.09 | −0.01, 0.18 | 33.37 | 0.0 | 0.771 |
| Ethiopia | 1 | 0.37 | 0.15, 0.60 | 5.74 | 50.2 | 0.156 | |
| Iran | 2 | 0.18 | 0.08, 0.29 | 27.00 | 41.3 | 0.182 | |
| Nigeria | 2 | 0.20 | 0.08, 0.31 | 21.46 | 29.6 | 0.234 | |
| Spain | 1 | 0.21 | −0.25, 0.68 | 1.35 | 0.0 | <0.001 | |
| Turkey | 3 | 0.41 | 0.25, 0.57 | 11.07 | 49.5 | 0.008 | |
| Overall | 12 | 0.19 | 0.14, 0.24 | 100.0 | 49.5 | 0.008 | |
| Sulfonamides | China | 2 | 0.04 | −0.08, 0.15 | 73.00 | 0.0 | 0.976 |
| Malaysia | 1 | 0.39 | 0.07, 0.71) | 9.39 | 0.0 | < 0.001 | |
| Nigeria | 1 | 0.57 | −0.23, 0.91 | 8.09 | 0.0 | <0.001 | |
| Spain | 1 | 0.21 | −0.25, 0.68 | 4.42 | 0.0 | <0.001 | |
| Turkey | 1 | 0.81 | −0.25, 0.61 | 5.10 | 0.0 | <0.001 | |
| Overall | 6 | 0.13 | 0.03, 0.23 | 100.0 | 48.5 | 0.070 | |
| Tetracycline’s | China | 4 | 0.09 | −0.02, 0.19 | 29.93 | 0.0 | 0.810 |
| Ethiopia | 1 | 0.38 | 0.06, 0.69 | 3.20 | 0.0 | <0.001 | |
| Iran | 2 | 0.22 | 0.10, 0.34 | 21.17 | 82.7 | 0.016 | |
| Italy | 2 | 0.04 | −0.19, 0.26 | 6.50 | 0.0 | 0.913 | |
| Jordan | 1 | 0.12 | −0.33, 0.56 | 1.60 | 0.0 | <0.001 | |
| Korea | 1 | 0.18 | −0.13, 0.49 | 1.60 | 0.0 | <0.001 | |
| Malaysia | 1 | 0.87 | 0.72, 1.02 | 14.80 | 0.0 | <0.001 | |
| Nigeria | 1 | 0.71 | 0.43, 1.00 | 4.05 | 0.0 | <0.001 | |
| Turkey | 2 | 0.30 | 0.14, 0.46 | 12.69 | 15.4 | 0.277 | |
| Overall | 15 | 0.30 | 0.24, 0.35 | 100.0 | 84.8 | 0.001 |